2. Immunology/Inflammation
  3. CD276/B7-H3

CD276/B7-H3

 

CD276/B7-H3 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-P99740
    Mirzotamab Inhibitor
    Mirzotamab is an IgG1κ antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclax (HY-137774), an BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC)[1].
  • HY-P99157
    Omburtamab Inhibitor 98.27%
    Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research[1][2].